The week of November 11, 2013, saw release of the long-awaited update to what had become a stale approach to cholesterol management in the long-term war against cardiovascular disease. Is the document a radical departure from what had gone before? The answer is a resounding “yes.”
If common mechanisms underlying cryptogenic stroke can be clarified, we will need to re-evaluate the current approach to secondary prevention. Here, elucidation of "emoblic stroke of undetermined source."